Diagnosis and management of type 2 diabetes in children.
| Autor: | Garvick S; Sarah Garvick is associate program director of the PA program at Wake Forest School of Medicine and practices with the Appalachian District Health Department, both in Boone, N.C. At the time this article was written, Lilli Altenburg, Bailey Dunlap, Abby Fisher , and Amanda Watson were students in the PA program at Wake Forest School of Medicine. Tanya Gregory is an assistant professor and director of student services in the Department of PA Studies at Wake Forest School of Medicine in Winston-Salem, N.C. The authors have disclosed no potential conflicts of interest, financial or otherwise., Altenburg L, Dunlap B, Fisher A, Watson A, Gregory T |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | JAAPA : official journal of the American Academy of Physician Assistants [JAAPA] 2022 Jul 01; Vol. 35 (7), pp. 16-22. |
| DOI: | 10.1097/01.JAA.0000832648.15129.b8 |
| Abstrakt: | Abstract: The incidence of type 2 diabetes in children has risen 4.8% over the past decade, correlating with steadily rising obesity rates in children. Updated guidelines from the American Academy of Pediatrics and the American Diabetes Association encourage early identification and pharmacologic intervention for children with type 2 diabetes. Because of the aggressive disease course in children, comprehensive treatment must include prevention of complications such as diabetic nephropathy and neuropathy as well as management of comorbidities such as cardiovascular disease and dyslipidemia. Because the highest incidence of type 2 diabetes is reported in patients from racial or ethnic minority groups and those of low socioeconomic status, clinicians must work with patients and families to identify socioeconomic disparities that could affect adherence to diabetes management plans and to connect patients with community resources. (Copyright © 2022 American Academy of Physician Associates.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|